Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

$10 Million Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Published 22/12/2022, 13:35
© Reuters.  $10 Million Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
IXIC
-
DUOL
-

Benzinga - Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Dave & Buster's Entertainment

  • The Trade: Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) 10% owner Scott Ross acquired a total of 535,000 shares an average price of $33.51. To acquire these shares, it cost around $17.93 million.
  • What’s Happening: The company recently posted upbeat quarterly sales.
  • What Dave & Buster's Entertainment Does: Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports.

Astria Therapeutics

  • The Trade: Astria Therapeutics, Inc. (NASDAQ: ATXS) Director Joseph Edelman acquired a total of 908,265 shares at an average price of $11.01. To acquire these shares, it cost around $10 million.
  • What’s Happening: Astria Therapeutics recently announced preliminary results from a Phase 1a clinical trial of STAR-0215.
  • What Astria Therapeutics Does: Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: CNN Fear & Greed Index Remains In 'Fear' Zone Despite Dow Jumping Over 500 Points

Duolingo

  • The Trade: Duolingo, Inc. (NASDAQ: DUOL) 10% owner Durable Capital Partners LP bought a total of 121,207 shares at an average price of $72.43. To acquire these shares, it cost around $8.78 million.
  • What’s Happening: Duolingo, last month, issued Q4 revenue guidance with a midpoint below estimates.
  • What Duolingo Does: Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google (NASDAQ:GOOGL) Play and the Apple (NASDAQ:AAPL) App Store.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.